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Tyrosine kinase, phosphatidylinositol 3-kinase, and protein kinase
C regulate insulin-stimulated NaC1 absorption in the thick
ascending limb
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Tyrosine kinase, phospbatidyhnositol 3-kinase, and protein kinase C
regulate insulin-stimulated NaC1 absorption in the thick ascending limb.
We have previously shown a direct stimulatory effect of insulin on NaCI
absorption in the medullary thick ascending limb of Henle's loop (mTAL).
To further investigate the signal transduction involved, we determined
whether tyrosine kinase, phosphatidylinositol 3-kinase (P13-kinase),
and/or protein kinase C (PKC) regulate insulin-stimulated NaC1 absorp-
tion in the mTAL by in vitro microperfusion methods. In control experi-
ments, insulin increased transepithelial voltage (V) and net lumen-to-
bath Cl flux (J1). Genistein and methyl 2,5-dihydroxycinnamate, two
specific tyrosine kinase inhibitors, abolished the effects of insulin. Wort-
mannin, a specific P13-kinase inhibitor, inhibited the action of insulin. The
effects of insulin also were inhibited by staurosporin and calphostin C,
which are dissimilar inhibitors of PKC. These results indicate that insulin
stimulates NaCl absorption in the mTAL through tyrosine kinase, P13-
kinase, and PKC-mediated mechanisms. Moreover, because we have
reported previously that insulin causes no detectable change in cytosolic
free Ca2 in the mTAL cells, the present results also suggest that
insulin-induced PKC activation is not related to inositol 1,4,5-triphosphate
(1P3) production.
Insulin shows the antinatriuretic effect without changes in
glomerular filtration rate or renal blood flow [1—4]. Clearance
experiments [2, 3] and micropuncture studies [3, 4] have suggested
that the antinatriuretic effect of insulin in vivo is localized mainly
to the thick ascending limb of Henle's loop (TAL). Recently, we
and another group provided the evidence by in vitro microperfu-
sion methods that insulin directly stimulates NaC1 absorption in
the rabbit and mouse TAL [5, 6]. This effect of insulin in the TAL
may be mediated by activation of NaCI absorption involving
furosemide-inhibitable Na -K4 -2C1 cotransport [5] and inde-
pendent of activation of Na'7K adenosine triphosphatase [7].
The stimulatory effect of insulin on Na-K-2Cl cotransport is
shown not only in the TAL, but also in BC3H-1 myocytes [8],
which has been well characterized for insulin's actions. NaC1
absorption in the TAL is known to be stimulated by a number of
hormonal effectors that stimulate the production of adenosine
3',S'-cyclic monophosphate (cAMP)[9]. However, insulin does
not affect adenylate cyclase activity in the TAL [9], indicating that
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cAMP does not fulfill the role of a second messenger in the action
of insulin.
The current theory proposes that intrinsic tyrosine kinase
activity of the insulin receptor plays a central role in mediating
many of insulin's action [10]. Activation of the insulin receptor
tyrosine kinase causes phosphorylation of several intracellular
substrates such as insulin-receptor substrate-i (IRS-I) [11]. Phos-
phorylation of these substrates creates the specific binding site for
src homology-2 (SH2) domains in a regulatory subunit (p85) of
phosphatidylinositol 3-kinase (P13-kinase), which phosphorylates
the D-3 position of the inositol ring of phosphatidylinositol (P1),
P1 4-phosphate (P14-P), and P1 4,5-bisphosphate (P14,5-P2) to
produce P1 3-phosphate (P13-P), P1 3,4-bisphosphate (P13,4-P2),
and P1 3,4,5-triphosphate (P13,4,5-P3), respectively [12]. The
activation of P13-kinase mediates metabolic actions of insulin such
as antilipolysis and the stimulation of glucose transport [13, 14].
Another proposed mechanism of insulin's action has been the
involvement of protein kinase C (PKC) [15]. Some studies have
demonstrated that insulin stimulates diacylglycerol production
[16, 17] and increases PKC activity, which subsequently may play
an important role in the mediation of insulin's action [18—20].
However, the roles of tyrosine kinase, P13-kinase, and PKC in
insulin's actions in renal tubular transports are not clear.
The purpose of the present study was therefore to determine
whether tyrosine kinase, P13-kinase, and/or PKC regulate insulin-
stimulated NaC1 absorption in the TAL. To address these issues,
we examined the effects of these kinases inhibitors on insulin-
stimulated NaCl absorption in the isolated perfused medullary
TM. (mTAL).
Methods
In vitro microperfusion of isolated m TALs
Female Japanese White rabbits weighing 1.5 to 2.5 kg were fed
a standard laboratory diet and had free access to tap water. On the
day of the experiment, they were anesthetized with pentobarbital
sodium (35 mg/kg, intravenously), and the left kidney was quickly
removed, cut into thin slices, and stored in a chilled dissection
solution containing (in mmol/liter) 14 KCI, 44 K2HPO4, 14
KH2PO4, 9 NaHCO3, and 160 sucrose (pH 7.4). A single mTAL
was dissected from the inner stripe of the outer medulla using fine
forceps and transferred to a perfusion chamber mounted on an
inverted microscope (model IMT-2; Olympus, Tokyo, Japan). The
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tubule was then perfused according to the in vitro microperfusion
technique described by Burg and Green [21] with some modifi-
cations of Kondo, Yoshitomi and Imai [22j. The perfusion
chamber was also perfused at 38°C. Exchange of solutions in the
chamber was accomplished by a rotaly valve installed beside the
microscope, which allowed a rapid exchange of the bath solution,
as described by Kondo and Frömter [23]. The perfusate and the
bathing solution were identical, and the composition of the
solution used in this study was (in mmol/liter) 135 NaCl, 3 KCI, 1.5
CaCl2, I MgC12, 2 KH2PO4, 10 N-2-hydroxyethylpiperazine-N'-2-
ethanesulfonic acid, 5.5 glucose, and 5 L-alanine, adjusted to pH
7.4 by NaOH and gassed with 100% 02. This study was performed
in accordance with the Guide for Animal Experimentation,
Tohoku University and Tohoku University School of Medicine.
Measurements of transepithelial voltage
To monitor transepithelial voltage (Vte), the bath solution was
connected to a heat-pulled glass capillary that allowed the con-
tinuous outflow of 3 mol/liter KC1 solution. The KCI solution for
the flowing boundary also was connected to the calomel half-cell,
which was directly grounded. The perfusion pipette used to
monitor Vte was filled with the perfusate, connected to I mol/liter
KCI agar bridge in a thin polyethylene tube and then to a Ag-AgCl
wire. The wire was connected directly to one probe of a high-input
impedance electrometer (model FD-223; WPI, New Haven, CT,
USA). To avoid interference by the dilution potential of NaCl, the
lumina of the mTALs were perfused at more than 20 nl/min.
Measurements of net lumen-to-bath Cl flux
Net lumen-to-bath Ci flux (J) was determined by electrical
measurement with a double-barreled CL microelectrode dis-
cribed before [5]. After the luminal fluid was collected from the
nonperfused side of the tubule using the collection pipette, a
droplet of the solution was transferred to a chamber containing
silicon oil, and a double-barreled CL microelectrode was dipped
into the droplet to measure CL activity. The electrodes were
calibrated to 150, 45, and 15 mmol/liter of the pure NaCI solution
at room temperature before and after measuring the collected
samples of luminal fluid. Since volume absorption did not differ
significantly from zero in this segment, J1 was calculated from the
equation:
jci = VIL ([L1 — [CLI)
where V is the perfusion rate, L is tubular length, [CLIp and
[CLIC are Cl activity in perfusate and collected fluid, respec-
tively. In the present study, the perfusion rate in every period of
the experiment in which J1 was measured was approximately 5
nI/mm. There was no significant difference in the perfusion rates
among the different periods.
Chemicals
Bovine insulin and calphostin C were purchased from Sigma
Chemical (St. Louis, MO, USA). IGF-I was kindly provided by
Fujisawa Pharmaceutical Co., Ltd. Corning ion exchanger no.
477913 was purchased from Corning Medical (Medfield, MA,
USA). Genistein, wortmannin, staurosporin, and all other chem-
icals were purchased from Wako Pure Chemicals (Osaka, Japan).
All inhibitors were dissolved in DMSO at final concentration of
less than 0.1%.
Statistical analysis
Data are expressed as the mean SE. Statistical comparisons
between the control and experimental periods within a group were
made using the paired t-test, and comparisons between the two
groups were made using the unpaired t-test. Any value of P <0.05
was accepted as statistically significant.
Results
Effect of insulin on l' and J1 in the m TAL
Insulin increased dose-dependently Vu, as we have reported
previously [5] and a submaximal stimulatory concentration, that is,
10 mol/liter insulin was chosen for subsequent experiments. In
control experiments, insulin increased Vu, from 3.1 0.3 to 5.7
0.3 mV (N = 5, P < 0.001) and a from 143 15 to 292 37
pmol . mm' min1 (N = 5, P < 0.005). To confirm that the
stimulatory effect of insulin is mediated through insulin receptor
and not that for insulin growth factor-I (IGF-I), the effect of
IGF-I on Vu, was also examined. Vte did not change after a 20
minute incubation of io— mol/liter IGF-I (from 3.6 0.4 to
3.3 0.3 mV, N = 6, P> 0.05).
Effects of lyrosine kinase inhibitors on the action of insulin in the
m TAL
We examined the effects of two dissimilar inhibitors of tyrosine
kinase on the action of insulin. A total of 148 j.mol/liter genistein
and 100 tmol/Iiter methyl 2,5-dihydroxycinnamate were added to
the bath 30 minutes prior to incubation with insulin. In the
presence of genistein, which is a competitive inhibitor of ATP
binding to tyrosine kinase [24], basal Vu, and J1 were 2.8 0.4
mV and 140 8 pmol mm1 min1, respectively, and
insulin-stimulated Vte and J1 were 3.2 0.5 mV and 154 15
pmol mmt - min1, respectively. In the presence of methyl
2,5-dihydroxycinnamate, which is a competitive inhibitor of sub-
strate binding to tyrosine kinase [25], basal Vu, was 2.9 0.2 mV,
and insulin-stimulated Vte was 2.9 0.2 mV. Thus, genistein and
methyl 2,5-dihydroxycinnamate both abolished the effects of
insulin without changing the basal values (Figs. I and 2).
Effect of a P13-kinase inhibitor on the action of insulin in the
mTAL
We examined the effect of wortmannin, a specific P13-kinase
inhibitor [261, which was isolated from the culture broth of
Talaromyces wortmanii KY 12420 [27] on insulin-stimulated Va,.
One jimol/liter wortmannin was added to the bath 30 minutes
prior to incubation with insulin. In the presence of wortmanriin,
basal Vu, was 3.4 0.2 mV and insulin-stimulated Vu, was 4.1
0.2 mV. Thus, wortmannin inhibited the effect of insulin on V,
without changing the basal values (Fig. 3).
Effects of PKC inhibitors on the action of insulin in the mTAL
We examined the effects of two dissimilar inhibitors of PKC on
insulin-stimulated Vte and J1 50 nmol/Iiter staurosporin and
calphostin C were added to the bath 30 minutes prior to incuba-
tion with insulin. In the presence of staurosporin, which is a
multicyclic microbial product that has been characterized as a
potent inhibitor of the catalytic domain of PKC [281, basal V1, and
J1 were 3.3 0.4 mV and 152 8 pmol mm' min',
respectively, and insulin-stimulated Vu, and J were 3.3 0.4 mV
and 154 15 pmol mm - min1, respectively. In the presence
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Fig. 1. Effects of tyrosine kinase inhibitors on insulin-stimulated V in the
mTAL. A total of 148 j.rmol/liter genistein and 100 jsmol/liter metyl
2,5-dihydroxycinnamate were added 30 minutes prior to an incubation
with insulin. Basal values were measured following pretreatment with
drugs, and experimental values were measured 20 minutes following the
incubation with 10' mol/liter insulin. Data also were compared to the
values in control experiments without drugs. Five tubules were tested in
each group. Symbols are: (LI) basal; (U) insulin. *p < 0.05 versus the
values in control experiments.
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Fig. 2. Effect of genistein on insulin-stimulated Jc, in the mTAL. A total of
148 jrmol/liter genistein was added 30 minutes prior to incubation with
insulin. Collections for basal J1 determination were made following
pretreatment with genistein, and experimental collections were made 20
minutes following an incubation with 106 mol/liter insulin. Data also
were compared to the values in control experiments without genistein.
Five tubules were tested in each group. Symbols are: (LI) basal; (U)
insulin. P < 0.05 versus the values in control experiments.
of calphostin C, which is produced by Cladosporium cladospori-
oides and has been characterized as a potent inhibitor of the
regulatory domain of PKC [29], basal Vie and J were 3.0 0.3
mV and 145 10 pmol mm min , respectively, and
insulin-stimulated V1 and J1 were 3.1 0.4 mV and 150 20
pmol mm1 mint, respectively. Thus, staurosporin and
calphostin C inhibited the effects of insulin on and J1 without
changing the basal values (Figs. 4 and 5).
Discussion
Our previous study has shown that the stimulatory effect of
insulin on NaC! absorption in the mTAL is not mediated by
cAMP [5]. The present study has further indicated that insulin
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Fig. 3. Effect of wortmannin on insulin-stimulated Vte in the mTAL. A total
of 1 jrmol/liter wortmannin was added 30 minutes prior to incubation with
insulin. Basal values were measured following pretreatment with wort-
mannin, and experimental values were measured 20 minutes following
incubation with 10—6 mol/liter insulin. Data also were compared to the
values in control experiments without wortmannin. Five tubules were
tested in each group. Symbols arc: (LII) basal; (U) insulin. *P < 0.05 versus
the values in control experiments.
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Fig. 4. Effects of PKC inhibitors on insulin-stimulated V,,. in the mTAL. A
total of 50 nmol/liter staurosporin and caiphostin C were added 30
minutes prior to incubation with insulin. Basal values were measured
following pretreatment with drugs, and experimental values were mea-
sured 20 minutes following incubation with 106 mol/liter insulin. Data
also were compared to the values in control experiments without drugs.
Five tubules were tested in each group. Symbols are: (LII) basal; (U)
insulin. p < 0.05 versus the values in control experiments.
stimulates NaC1 absorption through tyrosine kinase, P13-kinase,
and PKC-mediated mechanisms.
Genistein and methyl 2,5-dihydroxycinnamate, the specific ty-
rosine kinase inhibitors, inhibited insulin-stimulated NaCI absorp-
tion (Figs. 1 and 2), suggesting that the effect of insulin depends
on the receptor's /3-subunit tyrosine autophosphorylation or ty-
rosine kinase substrate phosphorylation. In agreement with our
results, genistein inhibits insulin-stimulated Na transport in the
A6 cells, which are a distal nephron cell line from Xenopus laevis
and have properties similar to the mammalian distal nephron [30,
31]. Matsumoto et al [30] have reported that tyrosine kinase
inhibitors inhibit also basal Na transport in the A6 cells,
suggesting that a tonic tyrosine kinase activity modulates Na
transport. Although we used an equivalent concentration of
genistein in the present study, we found that genistein did not
-I- I
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Fig. 5. Effects of PKC inhibitors on insulin-stimulated Jr., in the mTAL. A
total of 50 nmol/liter staurosporin and calphostin C were added 30
minutes prior to incubation with insulin. Collections for basal J1 deter-
mination were made following pretreatment with drugs, and experimental
collections were made 20 minutes following incubation with I 0 mol/liter
insulin. Data also were compared to the values in control experiments
without drugs. Five tubules were tested in each group. Symbols are: ()
basal; (•) insulin. p < 0.05 versus the values in control experiments.
inhibit basal Vte and J.1 in the mTAL (Figs. 1 and 2). This
difference may be explained by differences between the cell lines
and/or the methods used in these experiments.
Our study demonstrated that the specific P13-kinase inhibitor
wortmannin inhibited insulin-stimulated NaC1 absorption (Fig. 3).
It has been reported that wortmannin inhibits insulin-induced
glucose transport and antilipolysis [13, 141. Thus far, no study on
role of P13-kinase in insulin's action in ion transports has been
published to date. We examined the effect of wortmannin at I
.rmol/liter in the present study. Yano et al reported that 1
j.tmol/liter wortmannin almost completely inhibited P13-kinase
and myosine light chain kinase, and had no effect on cyclic
AMP-dependent protein kinase, cyclic GMP-dependent protein
kinase, and Ca2/calmodulin-dependent protein kinase II, and
weakly inhibited PKC to 20% at 10 j.rmol/liter [261. The present
study shows that PI3-kinase mediates also effects of insulin on ion
transports. In agrement with our results, Northern blot analysis
demonstrated abundant expression of P13-kinase mRNA in the
kidney [321.
The present study also shows that PKC inhibitors inhibit
insulin-stimulated NaCl absorption (Figs. 4 and 5), strongly
suggesting that insulin-stimulated NaC1 absorption in the mTAL
depend on activation of PKC. Both staurosporin and calphostin C
completely abolished the effects of insulin at 50 nmol/liter. The
concentration of staurosporin here was relatively lower than those
reported in studies of insulin-stimulated hexose transport in
adipocytes and BC3H-1 myocytes [331. However, in the latter
study, staurosporin was added five minutes prior to treatment with
insulin, as opposed to 30 minutes in the present study. While the
present study suggests the involvement of PKC in insulin-stimu-
lated NaCI absorption, the possible effect of these PKC inhibitors
on other kinases cannot he ruled out. However, two different
inhibitors used in the present study showed a similar inhibitory
effect on insulin's action. In agreement with our results, PKC
inhibitors inhibit insulin-stimulated Na transport in the A6 cell
[311 and frog skin [34]. Similarly, phorbol esters stimulate the
Na-K-2Cl cotransport in vascular smooth muscle cells [35]
and human fibroblasts [36]. On the other hand, the effect of
insulin in the isolated perfused mTAL is not mimicked by phorbol
ester [371. In contrast to the single actions, phorbol ester stimu-
lates furosemide-sensitive Na uptake into the mTAL in cell
volume changes [38]. Atypical protein kinases C being insensitive
to phorbol esters might be involved in insulin's action in the
mTAL. At present we have no data to explain the discrepancy.
Because we have reported previously that insulin causes no
detectable change in cytosolic free Ca2 in the rabbit mTAL cells
[39], the present results also suggest that insulin-induced PKC
activation is not related to inositol 1,4,5-triphosphate (1P3) pro-
duction. In agreement with our suggestions, Cooper et al reported
that insulin increases PKC activity [181. It is also reported that
insulin does not affect inositol phosphates or cytosolic free Ca2
in BC3H-1 myocytes [40]. Three mechanisms of insulin-induced
PKC activation have been indicated. The first mechanism is
insulin-induced diacylglycerol synthesis [15]. Three potential al-
ternate routes of insulin-induced diacyiglycerol synthesis can be
considered [15]: (1) de novo synthesis from phosphatidic acid [16,
401; (2) hydrolysis of phosphatidyicholine [16]; and (3) hydrolysis
of phosphatidylinositol glycan [17]. These distinct mechanisms
can all lead to the production of a structually distinct species of
diacyiglycerol without 1P5-induced Ca2 mobilization. Second
mechanism is the activation of PKC by tyrosine phosphorylation.
Insulin stimulates tyrosine phosphorylation of a isoform of clas-
sical PKC [41] and isoforms of novel PKC [42]. The third
mechanism is the activation of PKC by P13-kinase metabolites.
P13,4-P2 and P13,4,5-P1 were recently reported to activate some
isoforms of PKC [43, 44]. Nakanishi, Brewer and Exton reported
that P13,4,5-P3 activates the isoform of atypical PKC [431. Toker
et a! reported that P13,4-P2 and P13,4,5-P3 activate also b, e, and
s isoforms of novel PKC [44]. Additionaly, the mRNA of a
isoform of classical PKC, b isoform of novel PKC, and the
isoform of atypical PKC are abundantly expressed in the kidney
[451. The probes of in situ hybridization to fi isoform of novel PKC
and isoform of atypical PKC showed strong labeling in the inner
stripe of the outer medulla [51. It is possible that insulin can
cause selective activation of isoforms of PKC and stimulate NaCl
transport in the mTAL. Thus far, the effects of insulin on
phosphoinositide metabolism, diacylglycerol synthesis and protein
kinase C regulation have not been directly examined in the
mTAL. To clarify the precise mechanism of insulin's action in the
mTAL cells, further studies are necessary.
Acknowledgments
This work was supported in part by a Grant-in-Aid from the Ministry of
Education, Science and Culture and by a research grant for cardiovascular
diseases (3C-5) from the Ministry of Health and Welfare of Japan. A
portion of this study was presented at the 13th International Congress of
Nephrology in Madrid, Spain, in 1995. We thank S. Matsumoto and C.
Mezawa for their technical assistance.
Reprint requests to Yoshiaki Kondo, M.D., Department of Pediatrics,
Tohoku University School of Medicine, Sei,yo-machi 1-1, Aoba-ku, Sendai
980, Japan.
References
1. NIZET A, LEFEBVRE P, CRABRE J: Control by insulin of sodium
potassium and water excretion by the isolated dog kidney. Pflugers
Arch 323:11—20, 1971
Control Staurosporin Calphostin C
Ito et al: Mechanisms of insulin s action in the TAL 1041
2. DEFRONZO RA, CooKe CR, ANDERES R, FALOONA GR, DAVIS PJ:
The effect of insulin on renal handling of sodium, potassium, calcium,
phosphate in man. J Clin Invest 55:845—855, 1975
3. DEFRONZO RA, GOLDBERG M, AGUS ZS: The effect of glucose and
insulin on renal electrolyte transport. J C/in Invest 58:83—90, 1976
4. KIRCHNER KA: Insulin increases loop segment chloride reabsorption
in the euglycemic rat. Am J Physiol 24:F1206—F1213, 1988
5. ITO 0, KONDO Y, TAKAHASHI N, KUDO K, IGARASHI Y, IMAI Y,
OMATA K, ABE K: Insulin stimulates NaCl transport in isolated
perfused MTAL of Henle's loop of rabbit kidney. Am J Physiol
267:F265—F270, 1994
6. MANDON B, SIGA E, CHABARDES D, FIRS0v D, ROINEL N, DC
ROUFFIGNAC C: Insulin stimulates Nat, Cl, Ca2, and Mg2 trans-
ports in TAL of mouse nephron. Am J Physiol 265:F361—F369, 1993
7. FERAILLE E, MARSY 5, CHEVAL L, BARLET-BAS C, KHADOURI C,
FAVRE H, DOUCET A: Site of antinatriuretic action of insulin along rat
nephron. Am J Physiol 263:F175—F179, 1992
8. WEIL-MASLANSKY E, GUTMAN Y, SASSON S: Insulin activates furo-
semide-sensitive K and Cl uptake system in BC3HI cells. Am J
Physiol 267:C932—C939, 1994
9. MOREL F: Sites of hormone action in the mammalian nephron. Am J
Physiol 240:F159—F164, 1981
10. ROSEN OM: After insulin binds. Science 237:1452—1458, 1987
11. SUN XJ, ROTHENBERG P, KAHN CR, BACKER JM, ARAKI F, WILDEN
PA, CAHILL DA, GOLDSTEIN BJ, WHITE MF: Structure of the insulin
receptor substrate IRS-I defines a unique signal transduction protein.
Nature 352:73—77, 1991
12. CANTLEY LC, AUGER KR, CARPENTER C, DUCKWORTH B, GRAZIANI
A, KAPELLER R, SOLTOFF 5: Oncogenes and signal transduction. Cell
64:281—302, 1991
13. OKADA T, K.wANo Y, SAKAKIBARA T, HAZEKI 0, UI M: Essential
role of phosphatidylinositol 3-kinase in insulin-induced glucose trans-
port and antilipolysis in rat adipocytes. J Biol Chem 269:3568—3573,
1994
14. H.AKA K, YONEZAWA K, SAKUE H, ANDO A, KOTANI K, KITAMURA T,
KITAMURA Y, UEDA H, STEPHENS L, JACKSON TR, HAWKINS PT,
DRAND R, CLARK AE, HOLMAN GD, WATERFIELD MD, KASUGA M:
1-phosphatidylinositol 3-kinase activity is required for insulin-stimu-
lated glucose transport but not for RAS activation in CHO cells. Proc
NatlAcadSci USA 91:7415—7419, 1994
15. SALTIEL AR, CUATRECASAS P: In search of a second messenger for
insulin. Am J Physiol 255:Cl—C11, 1988
16. FARESE RV, KONDA TS, DAVIS JS, STANDAERT ML, POLLET RJ,
COOPER DR: Insulin rapidly increases diacylglycerol by activating de
novo phosphatidic acid synthesis. Science 236:586—589, 1987
17. SALTIEL AR, SHERLINE P, Fox JA: Insulin-stimulated diacylglycerol
production results from the hydrolysis of a novel phosphatidylinositol
glycan.JBiol Chem 262:1116—1121, 1987
18. COOPER DR, KONDA TS, STANDAERT ML, DAVIS JS, POLLET RJ,
FARESE RV: Insulin increases membrane and cytosolic protein kinase
C activity in BC3H-1 myocytes. J Biol Chem 262:3633—3639, 1987
19. DRAZMIN B, LEITNER JW, SUSSMAN KE, SHERMAN NA: Insulin and
glucose modulate protein kinase C activity in rat adipocytes. Biochem
Biophys Res Commun 156:570—575, 1988
20. PERSHADSINGH HA, SHADE DL, MCDONALD JM: Insulin-dependent
alteration of phorbol ester binding to adipocyte subcellular consti-
tutents. Evidence for the involvement of protein kinase C in insulin
action. Biochem Biophys Res Commun 145:1384—1389, 1987
21. BURG MB, GREEN N: Function of the thick ascending limb of Henle's
loop. Am J Physiol 224:659—668, 1973
22. KONDO Y, YOSHITOMI K, IMAL M: Effect of anion transport inhibitors
and ion substitution of Cl transport in TAL of Henle's loop. Am J
Physiol 253:F1206—F1215, 1987
23. KONDO Y, FROMTER F: Axial heterogeneity of sodium-bicarbonate
cotransport in proximal straight tubule of rabbit kidney. Pfiugers Arch
410:481-486, 1987
24. AKIYAMA T, ISHIDA J, NAKAGAWA 5, OGAWARA H, WATANABE 5, ITOH
N, SHIBUYA M, FUKAMI Y: Genistein, a specific inhibitor of tyrosine-
specific protein kinases. J Biol Chem 262:5592—5595, 1987
25. UMEZAWA K, HORI T, TAJIMA H, IMOTO M, IssHIKI K, TAKEUCHI T:
Inhibition of epidermal growth factor-induced DNA synthesis by
tyrosine kinase inhibitors. FEBS Lett 260:198—200, 1990
26. YANO H, NAKANISHI 5, KIMURA K, HANAI N, SAITOH Y, FUKUI Y,
NONOMURA Y, MATSUDA Y: Inhibition of histamine secretion by
wortmannin through the blockade of phospatidylinositol 3-kinase in
RBL-2H3 cells. J Biol Chem 268:25846—25856, 1993
27. NAKANISHI S, KAKITA 5, TAKAHASHI I, KAWAHARA K, TSUKUDA E,
SANO T, YAMADA K, YOSHIDA M, KASE H, MATSUDA Y, HASHJMOTO
Y, NONOMURA Y: Wortmannin, a microbial product inhibitor of
myosin light chain kinase. J Biol Chem 267:2157—2163, 1992
28. TAMAOKI T, NOMOTO H, TAKAHASHI I, KATO Y, MORIMOTO M,
TOMITA F: Staurosporin, a potent inhibitor of phosholipid/Ca
dependent protein kinase. Biochem Biophys Res Commun 135:397—
402, 1986
29. KOBAYASHI F, NAKANO H, M0RIM0T0 M, TAMAOKI T: Calphostin C
(UCN-1028C), a novel microbial compound, is a highly potent and
specific inhibitor of protein kinase C. Biochem Biophys Res Commun
159:548—553, 1989
30. MATSUMOTO PS, OHARA A, DUCHATELLE P, EATON DC: Tyrosine
kinase regulates epithelial sodium transport in A6 cells. Am J Physiol
264:C246—C250, 1993
31. RODRIGUEZ-COMMES J, ISALES C, KALGHATI L, GASALLA-HERRAIZ J,
HAYSLETr JP: Mechanism of insulin-stimulated electrogenic sodium
transport. Kidney mt 46:666—674, 1994
32. HU P, MONDINO A, SKOLNIK EY, SCHLESSINGER J: Cloning of a novel,
ubiquitously expressed human phosphatidylinositol 3-kinase and iden-
tification of its binding site on p85. Mol Cell Biol 13:7677—7688, 1993
33. STANDAERT ML, BUCKLEY DJ, ISHIZUKA T, HOFFMAN JM, COOPER
DR, POLLET RJ, FERASE RV: Protein kinase C inhibitors block insulin
and PMA-stimulated hexose transport in isolated rat adipocytes and
BC3H-1 myocytes. Metabolism 39:1170—1179, 1990
34. CIVAN MM, PETERSON-YANTORNO K, O'BRIEN TG: Insulin and
phorbol ester stimulate conductive Na transport through a common
pathway. Proc Nat! Acad Sci USA 85:963—967, 1988
35. OWEN NE: Effect of TPA on ion fluxes and DNA synthesis in vascular
smooth muscle cells. J Cell Biol 101:454—459, 1985
36. OWEN NE, PRASTEIN ML: Na/KJCI cotransport in cultured human
fibroblasts. J Biol Chem 260:1445—145 1, 1985
37. NEANT F, IMBERT-TEBOUL M, BAILLY C: Cyclic guanosine monophos-
phate is the mediator of platelet-activating factor inhibition on
transport by the mouse kidney thick ascending limb. J C/in Invest
94:1156—1162, 1994
38. EVELOFF J, WARNOCK DG: Activation of ion transport systems during
cell volume regulation. Am J Physiol 252:F1—F10, 1987
39. Iio 0, KONDO Y, TAKAHASHI N, OMATA K, ABE K: Role of calcium
in insulin-stimulated NaCl transport in medullary thick ascending
limb. Am J Physiol 269:F236—F241, 1995
40. FARESE RV, DAVIS JS, BARNES DE, STANDAERT ML, BABISCHXJN JS,
HOCK R, RosIc NK, POLLET RJ: The de novo phospholipid effect of
insulin is associated with increases in diacyiglycerol, but not inositol
phosphates or cytosolic Ca2. Biochem J 231:269—278, 1985
41. LIU F, ROTH RA: Insulin-stimulated tyrosine phospholylation of
protein kinase Ca. Biochem Biophys Res Commun 200:1570—1577,
1994
42. LI W, MISCHAK H, Yu JC, WANG LM, MUSHINSKI JF, HEIDARAN MA,
PIERCE JH: Tyrosine phosphorylation of protein kinase C-b in re-
sponse to its action. J Biol Chem 269:2349—2352, 1994
43. NAKANISHI H, BREWER KA, EXTON JH: Activation of the isozyme of
protein kinase C by phosphatidylinostol 3,4,5-trisphosphate. J Biol
Chem 268:13—16, 1993
44. TOKER A, MEYER M, REDDY KK, FALCK JR, ANEJA R, ANEJA S,
PARRA A, BURNS DJ, BALLAS LM, CANTLEY LC: Activation of protein
kinase C family members by the novel polyphoshoinositides Ptdlns-
3,4-P2 and Ptdlns-3,4,5-P3. J Biol Chem 269:32358—32367, 1994
45. OSTLUND E, MENDEZ CF, JACOBSSON G, FRYCKSTEDT J, MEISTER B,
APERIA A: Expression of protein kinase C isoforms in renal tissue.
Kidney mt 47:766—773, 1995
